Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 48% ± 21% | |
lung | 8 studies | 28% ± 11% | |
eye | 5 studies | 50% ± 21% | |
heart | 4 studies | 39% ± 9% | |
peripheral blood | 3 studies | 23% ± 1% | |
liver | 3 studies | 37% ± 20% | |
intestine | 3 studies | 17% ± 1% | |
adipose | 3 studies | 44% ± 12% | |
kidney | 3 studies | 27% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7308.59 | 1445 / 1445 | 100% | 43.13 | 183 / 183 |
breast | 100% | 8839.31 | 459 / 459 | 100% | 50.57 | 1113 / 1118 |
lung | 100% | 8061.31 | 578 / 578 | 99% | 27.85 | 1149 / 1155 |
intestine | 100% | 8168.03 | 966 / 966 | 99% | 23.49 | 524 / 527 |
brain | 99% | 4667.27 | 2626 / 2642 | 100% | 28.04 | 702 / 705 |
bladder | 100% | 8055.48 | 21 / 21 | 99% | 24.11 | 497 / 504 |
stomach | 100% | 5297.56 | 359 / 359 | 99% | 26.14 | 282 / 286 |
thymus | 100% | 6775.67 | 653 / 653 | 98% | 20.44 | 591 / 605 |
pancreas | 99% | 3628.43 | 325 / 328 | 98% | 20.86 | 175 / 178 |
skin | 100% | 9170.87 | 1809 / 1809 | 97% | 27.37 | 457 / 472 |
uterus | 100% | 8820.25 | 170 / 170 | 97% | 22.96 | 443 / 459 |
prostate | 100% | 6419.47 | 245 / 245 | 96% | 25.10 | 484 / 502 |
ovary | 100% | 8762.74 | 180 / 180 | 96% | 18.55 | 414 / 430 |
kidney | 100% | 3742.78 | 89 / 89 | 90% | 15.45 | 810 / 901 |
adrenal gland | 100% | 4747.40 | 258 / 258 | 85% | 10.68 | 196 / 230 |
liver | 97% | 2271.07 | 220 / 226 | 78% | 9.98 | 318 / 406 |
adipose | 100% | 8190.22 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 8309.06 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 25.76 | 29 / 29 |
muscle | 100% | 7518.42 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6109.26 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.81 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 25.31 | 44 / 45 |
heart | 96% | 4426.57 | 825 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 89% | 8362.53 | 829 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 89% | 25.36 | 71 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071629 | Biological process | cytoplasm protein quality control by the ubiquitin-proteasome system |
GO_0006281 | Biological process | DNA repair |
GO_0070979 | Biological process | protein K11-linked ubiquitination |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0140861 | Biological process | DNA repair-dependent chromatin remodeling |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0006974 | Biological process | DNA damage response |
GO_0042307 | Biological process | positive regulation of protein import into nucleus |
GO_0050847 | Biological process | progesterone receptor signaling pathway |
GO_0045879 | Biological process | negative regulation of smoothened signaling pathway |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0071630 | Biological process | nuclear protein quality control by the ubiquitin-proteasome system |
GO_0033696 | Biological process | heterochromatin boundary formation |
GO_0035519 | Biological process | protein K29-linked ubiquitination |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0140455 | Biological process | cytoplasm protein quality control |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0034450 | Molecular function | ubiquitin-ubiquitin ligase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0043130 | Molecular function | ubiquitin binding |
Gene name | UBR5 |
Protein name | Alternative protein UBR5 E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) Ubiquitin protein ligase E3 component n-recognin 5 UBR5 protein |
Synonyms | KIAA0896 EDD1 HYD EDD |
Description | FUNCTION: E3 ubiquitin-protein ligase which is a component of the N-end rule pathway. Recognizes and binds to proteins bearing specific N-terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation (By similarity). Involved in maturation and/or transcriptional regulation of mRNA by activating CDK9 by polyubiquitination. May play a role in control of cell cycle progression. May have tumor suppressor function. Regulates DNA topoisomerase II binding protein (TopBP1) in the DNA damage response. Plays an essential role in extraembryonic development. Ubiquitinates acetylated PCK1. Also acts as a regulator of DNA damage response by acting as a suppressor of RNF168, an E3 ubiquitin-protein ligase that promotes accumulation of 'Lys-63'-linked histone H2A and H2AX at DNA damage sites, thereby acting as a guard against excessive spreading of ubiquitinated chromatin at damaged chromosomes. . |
Accessions | ENST00000220959.8 [O95071-2] H0YBB4 Q49A65 ENST00000521922.5 ENST00000521566.1 E7ET84 ENST00000518205.5 H0YAV7 O95071 E7EMW7 L8E894 ENST00000520898.5 ENST00000520539.6 [O95071-1] E5RFK7 ENST00000519365.1 |